Fig. 7From: A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemiaDifferences in TME characteristics between high- and low-risk score groups. A Alluvial plots show the distribution of molecular subtypes, risk-score groups, and vital status of patients. B, C Differences in ICD scores between high- and low-risk groups and the correlation between risk scores and ICD scores. D–G Differences in immune cell infiltration (D), immune checkpoint expression (E), TIDE score (F), and tumor marker pathway enrichment score (G) between high- and low-risk groupsBack to article page